Business-Standard.com -- Sun Pharmaceutical Industries, which has been fighting for control of Israel’s Taro Pharmaceutical, has opened a new war front. For the first time, Sun’s Chairman and Managing Director, Dilip Shanghvi, has directly warned the professional directors on Taro’s board against siding with its founder-promoter-chairman, Barrie Levitt.
